Involvement of the X chromosome in non-Hodgkin lymphoma - PubMed (original) (raw)
Affiliations
- PMID: 10862030
Involvement of the X chromosome in non-Hodgkin lymphoma
H L McDonald et al. Genes Chromosomes Cancer. 2000 Jul.
Abstract
Gain of an X chromosome is observed as a secondary, acquired karyotypic alteration in a significant proportion of malignant lymphomas. To determine the potential involvement of X-linked genes in neoplastic development, we have analyzed the inactivation status of the supernumerary X chromosome in lymphomas in both male and female patients. In males, neither methylation of FMR1 nor expression of XIST was detected, demonstrating that the duplicated chromosome was not subject to inactivation. In females, both expressed polymorphisms and polymorphisms associated with methylation differences between the active and inactive X chromosome were analyzed to determine whether the duplicated chromosome was active or inactive. To facilitate this analysis, allele-specific PCR primers were designed for detection of previously described polymorphisms in the IDSX and G6PD genes. The female lymphomas were shown to be clonal in origin, and duplication of either the active (5 cases) or inactive (4 cases) X chromosome was observed. Correlations between clinical status and the inactivation status of the X chromosome involved in the duplication were not observed in our relatively small sample, although 4/4 informative cases with a t(14;18) showed duplication of the active X chromosome. In the course of these studies, we detected hypermethylation of the androgen receptor (AR) locus in an extremely high proportion of both male (7/9) and female (9/10) samples. These results are discussed with respect to whether sex chromosome aneuploidies in tumors are involved in, or simply the result of, the neoplastic process. Genes Chromosomes Cancer 28:246-257, 2000.
Copyright 2000 Wiley-Liss, Inc.
Similar articles
- The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors.
Kawakami T, Okamoto K, Sugihara H, Hattori T, Reeve AE, Ogawa O, Okada Y. Kawakami T, et al. J Urol. 2003 Apr;169(4):1546-52. doi: 10.1097/01.ju.0000044927.23323.5a. J Urol. 2003. PMID: 12629412 - X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status.
Looijenga LH, Gillis AJ, van Gurp RJ, Verkerk AJ, Oosterhuis JW. Looijenga LH, et al. Am J Pathol. 1997 Aug;151(2):581-90. Am J Pathol. 1997. PMID: 9250171 Free PMC article. - Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group. Lose F, et al. J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28. J Natl Cancer Inst. 2008. PMID: 18957670 - Parental origin of normal X chromosomes in Turner syndrome patients with various karyotypes: implications for the mechanism leading to generation of a 45,X karyotype.
Uematsu A, Yorifuji T, Muroi J, Kawai M, Mamada M, Kaji M, Yamanaka C, Momoi T, Nakahata T. Uematsu A, et al. Am J Med Genet. 2002 Aug 1;111(2):134-9. doi: 10.1002/ajmg.10506. Am J Med Genet. 2002. PMID: 12210339 Review. - Recent advances in X-chromosome inactivation.
Heard E. Heard E. Curr Opin Cell Biol. 2004 Jun;16(3):247-55. doi: 10.1016/j.ceb.2004.03.005. Curr Opin Cell Biol. 2004. PMID: 15145348 Review.
Cited by
- Genomic and transcriptomic characterization of the human glioblastoma cell line AHOL1.
Ferreira WAS, Amorim CKN, Burbano RR, Villacis RAR, Marchi FA, Medina TS, Lima MMC, Oliveira EHC. Ferreira WAS, et al. Braz J Med Biol Res. 2021 Jan 15;54(3):e9571. doi: 10.1590/1414-431X20209571. eCollection 2021. Braz J Med Biol Res. 2021. PMID: 33470396 Free PMC article. - Androgen receptor expression in mantle cell lymphoma: Potential novel therapeutic implications.
Mostaghel EA, Martin PS, Mongovin S, Frayo S, Zhang A, Edlefsen KL, Press OW, Gopal AK. Mostaghel EA, et al. Exp Hematol. 2017 May;49:34-38.e2. doi: 10.1016/j.exphem.2017.01.001. Epub 2017 Jan 21. Exp Hematol. 2017. PMID: 28115200 Free PMC article. - Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets.
Fatima R, Akhade VS, Pal D, Rao SM. Fatima R, et al. Mol Cell Ther. 2015 Jun 12;3:5. doi: 10.1186/s40591-015-0042-6. eCollection 2015. Mol Cell Ther. 2015. PMID: 26082843 Free PMC article. - Physiological roles of long noncoding RNAs: insight from knockout mice.
Li L, Chang HY. Li L, et al. Trends Cell Biol. 2014 Oct;24(10):594-602. doi: 10.1016/j.tcb.2014.06.003. Epub 2014 Jul 9. Trends Cell Biol. 2014. PMID: 25022466 Free PMC article. Review. - Risk Factors of Follicular Lymphoma.
Ma S. Ma S. Expert Opin Med Diagn. 2012 Jul 1;6(4):323-333. doi: 10.1517/17530059.2012.686996. Epub 2012 May 8. Expert Opin Med Diagn. 2012. PMID: 22754588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous